Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the effect of tofacitinib and TNF inhibitor in ulcerative colitis
IRCT20190717044255N8Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tofacitinib in autoimmune colitis (2 arms), sponsored by Arak University of Medical Sciences. Started Sep 2024; status: completed.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20190717044255N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190717044255N8.